镰状细胞病临床试验招募信息（全球在招）
这里汇总了全球正在招募患者的 镰状细胞病（国际通用名 sickle cell disease）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。
正在招募的镰状细胞病新药试验
Hemoglobin Disorders in Egypt: Sickle Cell Disease Ain Shams University Institutional Registry
不适用招募中EgyptNCT07800247T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
I 期 / II 期招募中美国NCT03653338High-flow Oxygen for Vaso-occlusive Pain Crisis
不适用招募中法国NCT03976180Pulmonary Functions in Sickle Cell Disease: Response to Acu-TENS
不适用招募中EgyptNCT06757829Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
I 期 / II 期招募中美国NCT02447874Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease
不适用招募中美国NCT06555939Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
II 期招募中美国NCT06016634Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
I 期招募中美国NCT07566494Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
不适用招募中美国NCT06385886Functional Ovarian Reserve in Sickle Cell Disease
不适用招募中美国NCT07392216Natural History of Sickle Cell Disease
不适用招募中美国NCT00081523Cognitive Remediation Intervention to Prepare for Transition of Care
II 期招募中美国NCT05336201
镰状细胞病试验不在中国大陆，还能参加吗？
可以尝试四条现实路径：查找国内同类试验、申请同情用药与扩展准入、赴境外研究中心入组、直接写信给申办方申请在华开展。本站提供中英文对照的咨询信模板，患者和家属填写基本情况即可生成。